MOTS-C Peptide UK: Research Overview, Laboratory Use & Scientific Context

September 27, 2026 · By My Store 3 Admin

MOTS-C is a mitochondria-derived signalling peptide that has attracted growing academic interest in the UK and internationally, particularly within ageing biology, metabolic research, and longevity science. This article provides a UK-focused research overview of MOTS-C — what it is, where the current science stands, what researchers in the UK should know about its laboratory use, and where to find properly documented research-grade material.

All Bloom Vitality products are supplied strictly for in vitro laboratory and research use only.

What is MOTS-C?

MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino acid peptide encoded within the mitochondrial genome — a discovery that represented a significant departure from the assumption that mitochondria primarily function as passive energy producers. First identified in 2015 by Lee et al. at the University of Southern California, MOTS-C was shown to act as an active signalling molecule, influencing cellular metabolism and stress responses from within the mitochondria themselves.

Its sequence — MRWQEMGYIFYPRKLR — is highly conserved across mammalian species, suggesting evolutionary significance. At approximately 2.17 kDa, it is a small peptide relative to many research compounds, but its mitochondrial origin and proposed nuclear translocation under metabolic stress have made it a subject of considerable academic interest.

For a detailed account of the molecular profile and mechanism, see: MOTS-C: Mitochondrial Peptide Research Overview. For a critical appraisal of the evidence base, see: MOTS-C Research: Evidence Quality, Preclinical Data & Scientific Landscape.

Why MOTS-C Is of Research Interest

Several characteristics distinguish MOTS-C from most synthetic research peptides:

Endogenous origin — MOTS-C is naturally produced in the human body. Like NAD+ and GHK-Cu, it is an endogenous molecule that declines with age, which positions it differently from purely synthetic compounds in longevity research contexts.
Mitochondrial encoding — Most peptides studied in research contexts are encoded by nuclear DNA. MOTS-C is encoded by the mitochondrial genome, making it the first mitochondria-derived peptide shown to act as a systemic signalling molecule.
Nuclear translocation — Under metabolic stress, MOTS-C has been shown to translocate to the nucleus, where it modulates gene expression. This bidirectional mitochondria-nucleus communication represents a mechanism not previously described for mitochondria-derived molecules.
AMPK pathway involvement — MOTS-C is proposed to activate AMPK (AMP-activated protein kinase), a central regulator of cellular energy homeostasis, via inhibition of the folate cycle and downstream AICAR accumulation.

Current Research Landscape

MOTS-C research remains predominantly preclinical. The published literature to date has investigated several areas of interest:

Metabolic regulation — Rodent studies have demonstrated that MOTS-C administration improves insulin sensitivity and glucose tolerance, particularly in models of diet-induced obesity. A 2015 study in Cell Metabolism (Lee et al.) established the foundational mechanistic and metabolic findings.
Age-related metabolic decline — MOTS-C levels have been reported to decline with age in human studies, paralleling the age-related decline observed in NAD+ and other endogenous longevity-relevant molecules.
Exercise mimetics — Research has investigated whether MOTS-C can replicate aspects of the metabolic adaptations associated with physical exercise, including mitochondrial biogenesis and AMPK activation in skeletal muscle models.
Longevity models — MOTS-C has been investigated in longevity-focused preclinical models, with some studies reporting effects on healthspan-related parameters.

Human interventional data is not yet available. For a full critical appraisal of what is and is not established, see: MOTS-C Research: Evidence Quality, Preclinical Data & Scientific Landscape.

MOTS-C in the Context of UK Longevity Research

Academic interest in mitochondria-derived peptides has grown steadily within UK research institutions, alongside broader interest in longevity compounds such as NAD+ precursors, senolytic agents, and endogenous peptides. MOTS-C sits within this broader research context — an endogenous molecule with a proposed role in metabolic regulation and mitochondrial signalling that is attracting increasing attention as the mechanisms of biological ageing become better characterised.

For researchers also investigating related endogenous compounds, our Research Library covers the longevity compound landscape in depth: see Longevity Peptides: GHK-Cu, NAD+ and MOTS-C Research Overview.

Laboratory Documentation & Quality Standards

For UK researchers, compound quality and documentation are essential methodological considerations. Key parameters to verify for research-grade MOTS-C:

Purity by HPLC (≥98% by peak area)
Identity confirmation by mass spectrometry (theoretical molecular weight: approximately 2,174 Da)
Batch-specific Certificate of Analysis from an independent, accredited laboratory
Lyophilised format for stability during storage and shipping

Bloom Vitality supplies MOTS-C 40mg as a lyophilised research vial, independently third-party tested for purity and identity. Batch-specific Certificates of Analysis are available via our Certificates & Documentation page. Testing methodology is described on the Testing & Quality page.

For guidance on interpreting CoA documentation and HPLC data, see: Peptide Certificate of Analysis: How to Read, Verify and Interpret CoA Documentation.

Related Research Compounds

NAD+ 500mg — endogenous coenzyme central to mitochondrial energy metabolism and sirtuin activation
GHK-Cu 100mg — naturally occurring copper-binding tripeptide with investigated roles in tissue remodelling and gene expression